Evidence map›Paper›PMID 37658978›Full record

SynthesisEndocrine2024

Ablation techniques or active surveillance compared to surgical resection in patients with low-risk papillary thyroid cancer: a systematic review and meta-analysis.

Tannya Ledesma-Leon, Paola Solis-Pazmino, Eddy P Lincango, Luis A Figueroa, Joshua Ellenhorn, Yosef Nasseri, Jason Cohen, Minerva Romero-Arenas, Cristhian Garcia, Alvaro Sanabria and 10 more

Abstract readSystematic ReviewMeta-AnalysisComparative Study
PubMed Publisher
In one paragraph

Synthesis in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Ablative Technologies for Thyroid Nodules: A Health Technology Assessment.Ontario health technology assessment series · 2026
    Pooled it
  3. Outcomes and effectiveness of active surveillance for low-risk papillary thyroid carcinoma: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Pooled it
  4. Article
  5. Review
  6. Review
  7. Ablative Therapies in Low-Risk Thyroid Cancer.Annals of surgical oncology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Thermal Ablation for Papillary Thyroid Carcinoma.JAMA otolaryngology-- head & neck surgery · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 3 countries.

Tannya Ledesma-Leon *Universidad Central del Ecuador, Facultad de Ciencias Médicas, Quito, Ecuador.
Paola Solis-Pazmino *CaTaLiNA- Cancer de Tiroides en Latino America, Quito, Ecuador.
Eddy P Lincango *CaTaLiNA- Cancer de Tiroides en Latino America, Quito, Ecuador.
Luis A FigueroaUniversidad Central del Ecuador, Facultad de Ciencias Médicas, Quito, Ecuador.
Joshua EllenhornSurgery Group Los Angeles, Los Angeles, CA, USA.
Yosef NasseriSurgery Group Los Angeles, Los Angeles, CA, USA.
Jason CohenSurgery Group Los Angeles, Los Angeles, CA, USA.
Minerva Romero-ArenasDepartment of Surgery, Weill Cornell Medicine New York Presbyterian Brooklyn Methodist Hospital, New York, NY, USA.
Cristhian GarciaInstituto de la Tiroides y Enfermedades de Cabeza y Cuello, Quito, Ecuador.
Alvaro SanabriaDepartment of Surgery, Universidad de Antioquia. -Centro de Excelencia en Enfermedades de Cabeza y Cuello. CEXCA, Medellin, Colombia.
Tatiana RojasCaTaLiNA- Cancer de Tiroides en Latino America, Quito, Ecuador.
Junior Torres-RománCaTaLiNA- Cancer de Tiroides en Latino America, Quito, Ecuador.
Emilia CamachoCaTaLiNA- Cancer de Tiroides en Latino America, Quito, Ecuador.
Sebastian VallejoKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, 55905, USA.
Benjamin Alvarado-MaflaCaTaLiNA- Cancer de Tiroides en Latino America, Quito, Ecuador.
Sophie DreamMedical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
Benjamin C JamesBeth Israel Deaconess Medical Center Department of Surgery, 484273, Surgery, 185 Pilgrim Road, Palmer 605, Boston, MA, 02115, USA.
Oscar J PonceCaTaLiNA- Cancer de Tiroides en Latino America, Quito, Ecuador.
Arun SharmaMultiCare Health System Tacoma General Hospital, Tacoma, WA, USA.
Juan P BritoKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, 55905, USA. brito.juan@mayo.edu.ORCID 0000-0003-1840-1745
Facultad Latinoamericana de Ciencias Ecuador · ECCentral University of Ecuador · ECBeth Israel Deaconess Medical Center · USMayo Clinic · USMayo Clinic in Florida · USMedical College of Wisconsin · USMultiCare Health System · USNewYork–Presbyterian Brooklyn Methodist Hospital · USUniversidad de Antioquia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global prevalence of thyroid cancer is on the rise. About one-third of newly diagnosed thyroid cancer cases comprise low-risk papillary thyroid cancer (1.5 cm or more minor). While surgical removal remains the prevailing approach for managing low-risk papillary thyroid cancer (LPTC) in patients, other options such as active surveillance (AS), radiofrequency ablation (RFA), microwave ablation (MWA), and laser ablation (LA) are also being considered as viable alternatives. This study evaluated and compared surgical thyroid resection (TSR) versus non-surgical (NS) methods for treating patients with LPTC.

methodsThe study encompassed an analysis of comparisons between surgical thyroid resection (TSR) and alternative approaches, including active surveillance (AS), radiofrequency ablation (RFA), microwave ablation (MWA), or laser ablation (LA). The focus was on patients with biopsy-confirmed low-risk papillary thyroid cancer (LPTC) of less than 1.5 cm without preoperative indications of local or distant metastasis. The primary outcomes assessed were recurrence rates, disease-specific mortality, and quality of life (QoL). Data were collected from prominent databases, including Cochrane Database, Embase, MEDLINE, and Scopus, from inception to June 3rd, 2020. The CLARITY tool was utilized to evaluate bias risk. The analysis involved odds ratios (OR) with 95% confidence intervals (CI) for dichotomous outcomes, as well as mean differences (MD) and standardized mean differences (SMD) for continuous outcomes. The study is registered on PROSPERO under the identifier CRD42021235657.

resultsThe study incorporated 13 retrospective cohort studies involving 4034 patients. Surgical thyroid resection (TSR), active surveillance (AS), and minimally invasive techniques like radiofrequency ablation (RFA), microwave ablation (MWA), and laser ablation (LA) were performed in varying proportions of cases. The analysis indicated that specific disease mortality rates were comparable among AS, MWA, and TSR groups. The risk of recurrence, evaluated over different follow-up periods, showed no significant differences when comparing AS, RFA, MWA, or LA against TSR. Patients undergoing AS demonstrated better physical health-related quality of life (QoL) than those undergoing TSR. However, no substantial differences were observed in the overall mental health domain of QoL when comparing AS or RFA with TSR. The risk of bias was moderate in nine studies and high in four.

conclusionLow-quality evidence indicates comparable recurrence and disease-specific mortality risks among patients with LPTC who underwent ablation techniques or active surveillance (AS) compared to surgery. Nevertheless, individuals who opted for AS exhibited enhanced physical quality of life (QoL). Subsequent investigations are warranted to validate these findings.

Indexed as

Ablation TechniquesThyroid Cancer, PapillaryThyroidectomyThyroid NeoplasmsWatchful WaitingHumansLaser TherapyQuality of LifeRadiofrequency AblationTreatment OutcomeAblation TechniquesActive surveillancePapillary thyroid cancerThyroidectomy

Identifiers

PMID37658978
OpenAlexW4386392518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.